Expanded Medicaid coverage with Horizon BCBS, UnitedHealthcare, and Wellpoint, coupled with Ophelia's pre-existing commercial health insurance relationships, deliver affordable, evidence-based medical treatment for opioid addiction to 3 million New Jerseyans Opioids claimed the lives of 2,651 New Jerseyans in 2022 amid an ongoing nationwide opioid epidemic NEW YORK , Oct. 2, 2024 /PRNewswire/ -- Ophelia , a virtual opioid addiction treatment provider, today announced that it is now serving Medicaid patients statewide in New Jersey . Ophelia has been serving commercial health plan members and uninsured New Jerseyans since 2022.
The Medicaid coverage expansion now provides 3 million New Jersey residents access to medications for opioid use disorder (MOUD), an evidence-based approach to OUD care that's considered the gold standard by the Centers for Disease Control and Prevention (CDC). Within the last two decades, 645,000 Americans died from an opioid overdose. In 2022 alone, there were more than 2,500 opioid-related overdose deaths in New Jersey , yet access to quality MOUD treatment providers is extremely limited and difficult to find.
Additionally, only one-third of community outpatient mental health treatment facilities in states with a high rate of opioid addiction offer MOUD treatment. Ophelia is addressing this crisis through its virtual-first care model, making treatment both easily accessible and affordable with expanded insurance coverage. Ophelia's in-network coverag.